Stem cell Treatment for Type 1/2 Diabetes Mellitus Program

• Сабақ жасушаларымен емдеу
• Қант диабеті кезінде діңгекті жасушалармен терапия
• Инфузиялық витамин терапиясы
• Консультация дәрігері
• Қан талдаулары

• 3 күндер ауруханада
• 7 күндер қонақ үйде

• VIP трансфер (премиум-санаттағы көлік, әуежай, қонақүй және клиника арасындағы барлық трансферлер)

IMPORTANT NOTICE

This is an example treatment plan provided to give you an initial idea of the possible treatment protocol and estimated cost.

The example below is based on a patient weighing approximately 70 kg. Our clinic’s general dosing protocol is approximately 1–2 million stem cells per kilogram of body weight.

The final dosage, treatment schedule, and price will be confirmed after our medical team reviews the patient’s body weight, medical history, laboratory results, and current treatment.

After reviewing this offer, if you remain interested in treatment, please send the information requested below. Our medical team will prepare a free personalized treatment plan for you.

--------------------

Estimated treatment cost:

Option 1 – 70 million UC-MSCs
Estimated price: THB 473,000
Approximately USD 14,100

Option 2 – 140 million UC-MSCs
Estimated price: THB 740,000
Approximately USD 22,100

The USD amounts are approximate and may change according to the exchange rate. The final price will depend on the required stem cell dosage and any additional services recommended by the doctor.

--------------------

Estimated treatment plan may include:

• UC-MSCs: 70 million or 140 million cells (Intravenous Injection)
• hTSC Exosomes: 20 billion particles (Intravenous Injection)
• Doctor consultation
• Comprehensive blood tests
• Blood test result consultation
• NAD+ (Intravenous Injection)
• Vega Signature Vitamins Drip (Intravenous Injection)
• Brain Peptide Therapy (Intravenous Injection)
• Placenta Extract (Intramuscular Injection)
• Post-treatment consultation

Procedure inclusions:
• Doctor’s fee
• Clinic operation fee
• Transportation between the airport, hotel, and clinic, round trip

The final combination of treatments will be adjusted according to the patient’s medical assessment and suitability.

--------------------

How stem cell therapy may support Type 1 Diabetes:

• Support for immune balance: Type 1 Diabetes involves immune activity against insulin-producing beta cells. UC-MSCs may help regulate immune and inflammatory signaling and support a more balanced biological environment.

• Support for the pancreatic environment: UC-MSCs release bioactive factors that may support tissue health, circulation, and the biological environment surrounding the pancreas and any remaining beta-cell function.

• Protection of remaining beta-cell function: A more balanced immune and inflammatory environment may help support any residual insulin-producing cell function. The treatment does not guarantee beta-cell restoration or regeneration.

• Support for glucose stability: Some patients may experience more stable blood glucose patterns or changes in insulin requirements over time. Any insulin adjustment must be made only under medical supervision.

• Support for vascular and nerve health: The anti-inflammatory and regenerative-support effects of UC-MSCs may help support circulation, nerve health, tissue repair, and wound-healing capacity.

If changes occur, they may develop gradually and may be monitored over approximately 3–6 months. Possible changes may include improved glucose stability, energy, circulation, or overall quality of life.

Stem cell therapy supports the body’s natural repair and regulatory processes rather than producing immediate medication-like effects. The response and timeframe vary from person to person.

--------------------

How stem cell therapy may support Type 2 Diabetes:

• Support for insulin sensitivity: UC-MSCs may help support the body’s response to insulin and more efficient glucose uptake.

• Support for pancreatic beta-cell function: Bioactive factors released by UC-MSCs may support the function and survival of remaining insulin-producing beta cells.

• Reduction of chronic inflammation: UC-MSCs have anti-inflammatory and immunomodulatory properties that may help regulate inflammation associated with Type 2 Diabetes.

• Support for glucose control: Some patients may experience more stable blood glucose levels and improved insulin sensitivity over time.

• Support for metabolic and vascular health: UC-MSCs release bioactive factors that may support tissue repair, circulation, nerve health, wound-healing capacity, and overall metabolic balance.

If changes occur, they may develop gradually and may be monitored over approximately 3–6 months. Possible changes may include improved glucose stability, energy, circulation, or overall quality of life.

Stem cell therapy supports the body’s natural repair and regulatory processes rather than producing immediate medication-like effects. The response and timeframe vary from person to person.

--------------------

Information required for a personalized treatment plan:

• Current body weight
• Drug allergies
• Previous or current treatments
• Cancer history
• Recent blood report or medical report
• Current insulin type, dosage, and daily schedule

--------------------

Stem cell therapy for Type 1 Diabetes is an alternative and supportive treatment. It is not a cure and cannot replace insulin therapy or standard diabetes care.

Patients must continue their prescribed insulin, glucose monitoring, dietary management, and regular follow-up with their treating doctor. Any change to insulin dosage must be made only under medical supervision.

Treatment responses vary from person to person, and no specific result can be guaranteed.

• Жеке дәрігер-координатор
• Сапарды ұйымдастыру — біздің серіктестерден төмендетілген бағамен билеттер мен қонақ үйлерді брондау
• Клиникаға бару барысында науқас мүдделерін қорғау